» Articles » PMID: 33299880

Novel Model to Predict the Prognosis of Patients with Stage II-III Colon Cancer

Overview
Journal Biomed Res Int
Publisher Wiley
Date 2020 Dec 10
PMID 33299880
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Different opinions exist on the relationship between the C-reactive protein-to-albumin ratio (CAR) and the prognosis of colon cancer. This study is aimed at evaluating the relationship between CAR and prognosis of stage II-III colon cancer and establishing a clinical prognosis model. Patients were randomised to a training set (566 cases) and validation set (110 cases). The relationship between CAR and clinicopathological variables was calculated, and the Kaplan-Meier method was used to analyse the overall survival (OS) rate of colon cancer. In the training set, colon cancer independent risk factors were included in the prognosis model and then tested in the validation set. The accuracy and discrimination of the model were assessed using the C-index and calibration curves. Compared with patients with low CAR, patients with high CAR showed significantly poorer survival ( = 0.020). In the multivariate analysis, CAR, carcinoembryonic antigen (CEA), lymph node metastasis, operation mode, and perineural invasion were identified as independent prognostic indicators and adopted to establish the prediction model. The C-index of the nomogram for predicting OS reached 0.751 in the training set and 0.719 in the validation set. The calibration curve exhibited good consistency. In the present study, the CAR may be an independent prognostic factor for stage II-III colon cancer, and the nomogram has a certain predictive value. However, further prospective large-sample research needs to be conducted to validate our findings.

Citing Articles

Persistent high levels of carcinoembryonic antigen after tumor resection are associated with poorer survival outcomes in patients with resected colon cancer.

Munoz-Montano W, Lopez-Basave H, Castillo-Morales A, Castillo-Morales C, Sanchez-Trejo K, Catalan R BMC Cancer. 2023; 23(1):678.

PMID: 37468881 PMC: 10354962. DOI: 10.1186/s12885-023-11126-4.


Development and validation of a prognostic nomogram for patients with stage II colon mucinous adenocarcinoma.

Huang J, Zhang Y, Zhou J, Fang M, Wu X, Luo Y Int J Colorectal Dis. 2022; 37(10):2173-2184.

PMID: 36149446 DOI: 10.1007/s00384-022-04251-2.


Nomograms based on lactate dehydrogenase to albumin ratio for predicting survival in colorectal cancer.

Hu Y, Zhou Y, Cao Y, Wang H, Yang Y, Jiang R Int J Med Sci. 2022; 19(6):1003-1012.

PMID: 35813299 PMC: 9254365. DOI: 10.7150/ijms.71971.


A Machine Learning-Based Investigation of Gender-Specific Prognosis of Lung Cancers.

Wang Y, Liu S, Wang Z, Fan Y, Huang J, Huang L Medicina (Kaunas). 2021; 57(2).

PMID: 33499377 PMC: 7911834. DOI: 10.3390/medicina57020099.

References
1.
Dolan R, McSorley S, Park J, Watt D, Roxburgh C, Horgan P . The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores. Br J Cancer. 2018; 119(1):40-51. PMC: 6035216. DOI: 10.1038/s41416-018-0095-9. View

2.
Dolan R, McSorley S, Horgan P, McMillan D . Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer. Medicine (Baltimore). 2018; 97(13):e0185. PMC: 5895435. DOI: 10.1097/MD.0000000000010185. View

3.
Suzuki S, Akiyoshi T, Oba K, Otsuka F, Tominaga T, Nagasaki T . Comprehensive Comparative Analysis of Prognostic Value of Systemic Inflammatory Biomarkers for Patients with Stage II/III Colon Cancer. Ann Surg Oncol. 2019; 27(3):844-852. DOI: 10.1245/s10434-019-07904-9. View

4.
Huh J, Kim H, Kim Y . Prognostic value of perineural invasion in patients with stage II colorectal cancer. Ann Surg Oncol. 2010; 17(8):2066-72. DOI: 10.1245/s10434-010-0982-7. View

5.
Konishi T, Shimada Y, Hsu M, Tufts L, Jimenez-Rodriguez R, Cercek A . Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome. JAMA Oncol. 2017; 4(3):309-315. PMC: 5885834. DOI: 10.1001/jamaoncol.2017.4420. View